[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359783-105":59,"doc-detail-359783-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-and-machine-learning-analyses-reveal-pik3cg-prkcd-and-trim22-as-potential-markers-of-poor-prognosis-and-immune-activation-in-glioblastoma","Multi-Omics and Machine Learning Analyses Reveal PIK3CG, PRKCD, and TRIM22 as Potential Markers of Poor Prognosis and Immune Activation in Glioblastoma","","Glioblastoma (GBM) is characterized by aggressive behavior and poor outcomes despite existing treatment strategies. This study identifies genes with high expression that show a paradoxical relationship with both worse survival and increased immune activity, aiming to support combination chemotherapeutic and immunotherapeutic approaches. Transcriptomic analyses of WHO grade IV gliomas used TCGA, CGGA, and GTEx, screening 12,041 genes with rank statistics, machine-learning survival modeling, and pathway network analysis, followed by IDH-wildtype subgroup validation under the 2021 WHO framework.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-and-machine-learning-analyses-reveal-pik3cg-prkcd-and-trim22-as-potential-markers-of-poor-prognosis-and-immune-activation-in-glioblastoma/359783/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-and-machine-learning-analyses-reveal-pik3cg-prkcd-and-trim22-as-potential-markers-of-poor-prognosis-and-immune-activation-in-glioblastoma/359783.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What genes were identified as potential biomarkers in this glioblastoma study?","Question",{"text":112,"@type":113},"PIK3CG, PRKCD, and TRIM22 were highlighted as key biomarkers linked to poor prognosis and immune activation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were candidate genes selected from the transcriptomic dataset?",{"text":117,"@type":113},"The analysis screened 12,041 genes and prioritized those showing paradoxical associations with prognosis and immune activity using rank statistics, machine-learning survival modeling, and pathway network analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What kind of validation was performed for the glioblastoma subgroup?",{"text":121,"@type":113},"Validation was conducted using only IDH-wildtype GBM cases, consistent with the 2021 WHO classification.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359783,1790641632,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","J Korean Med Sci. 2026 Apr 27;41(16):e130 [https://doi.org/10.3346/jkms.2026.41.e130](https://doi.org/10.3346/jkms.2026.41.e130)[ ](https://doi.org/10.3346/jkms.2026.41.e130)eISSN 1598-6357·pISSN 1011-8934  \nOriginal Article  \nNeuroscience  \nReceived: Apr 29, 2025  \nAccepted: Jul 21, 2025  \nPublished online: Mar 21, 2026  \nAddress for Correspondence:  \nSeoungWan Chae, MD, PhD Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Seoul 03181, Republic of Korea.  \nEmail: [chae_sw@hanmail.net](chae_sw@hanmail.net)  \nKyueng-Whan Min, MD, PhD Department of Pathology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, 712 Dongil-ro, Uijeongbu 11759, Republic of Korea. [Email: kyueng@hanyang.ac.kr](Email: kyueng@hanyang.ac.kr)  \n*Myung-Hoon Han and Yung-Kyun Noh contributed equally to this work.  \n© 2026 The Korean Academy of Medical Sciences.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([https://](https://)[ ](https://)[creativecommons.org/licenses/by-nc/4.0/](creativecommons.org/licenses/by-nc/4.0/)) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nORCID iDs  \nMyung-Hoon Han  [https://orcid.org/0000-0003-1728-5017](https://orcid.org/0000-0003-1728-5017)[ ](https://orcid.org/0000-0003-1728-5017)[Yung-Kyun Noh](Yung-Kyun Noh)  [https://orcid.org/0000-0002-6372-9267](https://orcid.org/0000-0002-6372-9267)  \nMulti-Omics and Machine Learning Analyses Reveal PIK3CG, PRKCD, and TRIM22 as Potential Markers of Poor Prognosis and Immune Activation in Glioblastoma  \nMyung-Hoon Han ,1* Yung-Kyun Noh ,2,3* Hyunkee Kim ,4 Kyu Shik Kim ,5 Dong-Hoon Kim ,6 Un Suk Jung ,7 Kyung Suk Lee ,8 Mi Jung Kwon ,9 Seoung Wan Chae ,6 and Kyueng-Whan Min  10  \n1Department of Neurosurgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea  \n2Department of Computer Science, Hanyang University, Seoul, Korea  \n3School of Computational Sciences, Korea Institute for Advanced Study, Seoul, Korea  \n4Department of Neurology, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea  \n5CardiOmics Program, Center for Heart and Vascular Research, Division of Cardiovascular Medicine, Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, USA 6Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea  \n7Department of Obstetrics and Gynecology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea  \n8Department of Pediatrics, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea  \n9Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea  \n10Department of Pathology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, Korea  \nABSTRACT  \nBackground: Glioblastoma (GBM) is one of the most aggressive brain tumors with a poor prognosis despite current treatment modalities. This study aimed to identify genes whose high expression is paradoxically associated with both poor survival and enhanced immune activity, as potential targets for combination chemotherapeutic and immunotherapeutic strategies. Methods: Transcriptomic data from patients with central nervous system World Health Organization (WHO) grade IV gliomas (based on the 2016 WHO classification) were analyzed, using datasets from The Cancer Genome Atlas (525 cases), the Chinese Glioma Genome Atlas (250 cases), and the Genotype-Tissue Expression (1,152 normal samples) . We initially screened 12,041 genes, prioritizing those showing a paradoxical association with prognosis and immune activation. Key genes were selected through rank statistics, machine-learning-based survival mod","cbCaibS8RgnHYiDv","https://ap.wps.com/l/cbCaibS8RgnHYiDv","pdf",6165657,22,"English","# Abstract\n## Background\n## Methods\n## Results\n## Validation","[{\"question\":\"What genes were identified as potential biomarkers in this glioblastoma study?\",\"answer\":\"PIK3CG, PRKCD, and TRIM22 were highlighted as key biomarkers linked to poor prognosis and immune activation.\"},{\"question\":\"How were candidate genes selected from the transcriptomic dataset?\",\"answer\":\"The analysis screened 12,041 genes and prioritized those showing paradoxical associations with prognosis and immune activity using rank statistics, machine-learning survival modeling, and pathway network analysis.\"},{\"question\":\"What kind of validation was performed for the glioblastoma subgroup?\",\"answer\":\"Validation was conducted using only IDH-wildtype GBM cases, consistent with the 2021 WHO classification.\"}]","Multi-Omics and Machine Learning Analyses Reveal PIK3CG, PRKCD, and TRIM22 as Potential Markers of Poor Prognosis and Immune Activation in Glioblastoma | PDF",1790137800,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4109fcbe3975e3c3620cedf49ed13cc.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/795fccdadcbe3b4c76df22307739e552.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b784fc505d960804a2727678921c84c3.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d504a733f11e09e1a1b445cb802593f2.webp",980,1306]